Clinical Trial Update: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

View source ↗

Summary

Post-approval study update for Medtronic's Intrinsic Antitachycardia Pacing (iATP) PAS in patients with ventricular tachycardia; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Drugs mentioned

• Intrinsic Antitachycardia Pacing (iATP) Post-Approval Study (PAS)

Snippet

Sponsor: Medtronic | Conditions: Ventricular Tachycardia | Status: ACTIVE_NOT_RECRUITING